Form 4: Omnicell Director Robin Seim Receives Stock Grant

Director Robin Seim received 6,143 shares of Omnicell stock as part of the company's equity incentive plan.

Summary

• Robin Gene Seim, a director at Omnicell, Inc., reported a transaction on May 21, 2024.
• Seim acquired 6,143 shares of common stock through a grant under the Issuer's equity incentive plan.
• The shares were granted in consideration of services as a Board Member pursuant to the Issuer's Board of Directors Compensation Plan.
• The price per share was $0.
• Following the transaction, Seim directly owns 40,525 shares of Omnicell stock.
• The restricted shares will vest in full on the date of the Issuer's 2025 Annual Meeting of Stockholders.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to positively as it aligns interests. There are no indications of negative sentiment.

Positives

• The grant of restricted shares aligns the director's interests with those of the shareholders.
• The equity incentive plan is a common method to attract and retain board members.

Future Outlook

The shares will vest in full on the date of the Issuer's 2025 Annual Meeting of Stockholders.

Industry Context

Stock grants to directors are a common practice in the industry to align their interests with those of the shareholders and incentivize them to contribute to the company's long-term success.

Comparison to Industry Standards

• Stock grants to board members are a common practice across publicly traded companies, particularly in the technology and healthcare sectors.
• Companies like Cerner (now Oracle Health) and McKesson also utilize equity compensation as part of their director compensation packages.
• The size of the grant is typical for a director at a company of Omnicell's size and market capitalization.

Stakeholder Impact

• The stock grant aligns the director's interests with those of the shareholders, potentially leading to better decision-making for the company's long-term success.

Next Steps

• The shares will vest on the date of the Issuer's 2025 Annual Meeting of Stockholders.

Key Dates